- Home
- KRMD vs ELA Comparison
KRMD vs ELA Comparison
Compare KRMD & ELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- ELA
- Stock Information
- Founded
- KRMD 1980
- ELA 1965
- Country
- KRMD United States
- ELA United States
- Employees
- KRMD N/A
- ELA N/A
- Industry
- KRMD Medical/Dental Instruments
- ELA Consumer Specialties
- Sector
- KRMD Health Care
- ELA Consumer Discretionary
- Exchange
- KRMD Nasdaq
- ELA Nasdaq
- Market Cap
- KRMD 187.5M
- ELA 173.1M
- IPO Year
- KRMD N/A
- ELA N/A
- Fundamental
- Price
- KRMD $4.60
- ELA $6.73
- Analyst Decision
- KRMD Strong Buy
- ELA Strong Buy
- Analyst Count
- KRMD 5
- ELA 1
- Target Price
- KRMD $4.50
- ELA $7.00
- AVG Volume (30 Days)
- KRMD 157.7K
- ELA 17.3K
- Earning Date
- KRMD 03-12-2025
- ELA 03-19-2025
- Dividend Yield
- KRMD N/A
- ELA N/A
- EPS Growth
- KRMD N/A
- ELA N/A
- EPS
- KRMD N/A
- ELA 0.25
- Revenue
- KRMD $31,993,796.00
- ELA $165,946,534.00
- Revenue This Year
- KRMD $20.04
- ELA $1.61
- Revenue Next Year
- KRMD $14.15
- ELA $6.30
- P/E Ratio
- KRMD N/A
- ELA $27.13
- Revenue Growth
- KRMD 11.57
- ELA N/A
- 52 Week Low
- KRMD $2.01
- ELA $4.20
- 52 Week High
- KRMD $5.05
- ELA $7.88
- Technical
- Relative Strength Index (RSI)
- KRMD 66.80
- ELA 39.08
- Support Level
- KRMD $4.16
- ELA $6.62
- Resistance Level
- KRMD $4.40
- ELA $7.05
- Average True Range (ATR)
- KRMD 0.23
- ELA 0.35
- MACD
- KRMD 0.03
- ELA -0.06
- Stochastic Oscillator
- KRMD 63.71
- ELA 42.47
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About ELA Envela Corporation
Envela Corp and its subsidiaries engage in diverse business activities within the recommerce sector. These include re-commercializing luxury hard assets, consumer electronics and IT equipment; and end-of-life recycling solutions. It operates through two segments, Consumer, and Commercial Services. The Consumer segment which generates key revenue for the company predominantly buys to resell or recycle luxury hard assets like jewelry, diamonds, gemstones, fine watches, rare coins and related collectibles, precious-metal bullion products, gold, silver, and other precious metals. The Commercial Services segment provides asset-disposition solutions to government agencies, middle-market firms, corporations, and other organizations.